Acta Pharmaceutica's Cover Image

Acta Pharmaceutica

The Journal of Croatian Pharmaceutical Society
Open Access
1.4
Impact Factor
4.5
CiteScore
Open Access | Aug 29, 2025
Niosome-based delivery systems for olanzapine: Formulation, characterisation, and kinetic evaluation
, , , , , ,  and   
Open Access | Jul 16, 2025
Synthesis of magnetic N-doped carbon dots as pH-responsive targeted molecule cargo and its antioxidant and antibacterial behaviour
, , ,  and   
Open Access | Jul 16, 2025
Recent advances in the treatment of non-alcoholic fatty liver disease with astragaloside IV
, , , , ,  and   

Open Access | Jul 16, 2025
Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway
, , , , ,  and   
Open Access | Jul 03, 2025
Design, synthesis, and evaluation of a novel fluorescent probe for competitive fluorescence polarization assay to screen galectin-8 inhibitors
, , , , , ,  and   
Open Access | Jul 03, 2025
Optimization of 6-(trifluoromethyl)pyrimidine derivatives as TLR8 antagonists
, , , , , ,  and   
Journal Information
Download Cover

Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.

AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.

To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.

AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.

Topics covered are:

  • drug design
  • molecular modelling/docking studies
  • pharmaceutical chemistry/medicinal chemistry
  • drug metabolism
  • analytics of drugs
  • pharmaceutical technology/formulation studies/nanosystems/cosmetology
  • pharmaceutical biotechnology
  • pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics
  • drug delivery/disposition and stability
  • pharmacognosy and phytopharmacy
  • pharmacology (clinical and animal)
  • toxicology
  • clinical pharmacy
  • pharmacovigilance
  • pharmaceutical and clinical biochemistry
  • pharmaceutical biology with genetics/pharmacogenomics/cell biology
  • pharmacoepidemiology/pharmacoeconomics/social pharmacy
  • physical pharmacy
  • radiopharmaceuticals
  • medicine (including diagnostics and therapy)
  • peptide and protein chemistry/protein design

Why subscribe and read

  • To get informed on the latest research in pharmaceutical and related sciences.

Why submit

  • fair and constructive peer review by the experts in the field,
  • editorial help and language revision services,
  • articles abstracted by online indexing services,
  • listed in WoS MJL by Clarivate.

Archiving

Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.

Plagiarism Policy

The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.

eISSN:
1846-9558
ISSN:
1330-0075
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Pharmacy, Pharmacy, other